Pathogenesis of hepatic encephalopathy

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Ciećko Michalska, Irena ^a   Szczepanek, Małgorzata ^a   Słowik, Agnieszka ^a   MacH, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMMONIA; FLUMAZENIL; GAMMA INTERFERON; GLUTAMATE SYNTHASE; GLUTAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MANGANESE; NEUROSTEROID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LIVER FAILURE; ALZHEIMER DISEASE; AMINO ACID TRANSPORT; ASTROCYTE; BACTERIAL OVERGROWTH; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; CLINICAL FEATURE; ENERGY METABOLISM; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; RISK FACTOR; SMALL INTESTINE; UREA CYCLE;

EID: 84872153114     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/642108     Document Type: Review

References (87)

1. Ferenci P., Lockwood A., Mullen K., Tarter R., Weissenborn K., Blei A. T., Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002 35 3 716 721 2-s2.0-0036191173 10.1053/jhep.2002.31250 (Pubitemid 34183979)
2. Prakash R., Mullen K. D., Mechanisms, diagnosis and management of hepatic encephalopathy. Nature Reviews Gastroenterology and Hepatology 2010 7 9 515 525 2-s2.0-77956393999 10.1038/nrgastro.2010.116
3. Weissenborn K., Ennen J. C., Schomerus H., Rückert N., Hecker H., Neuropsychological characterization of hepatic encephalopathy. Journal of Hepatology 2001 34 5 768 773 2-s2.0-0035018910 10.1016/S0168-8278(01)00026-5 (Pubitemid 32488796)
4. Duarte-Rojo A., Estradas J., Hernández-Ramos R., Ponce-de-León S., Córdoba J., Torre A., Validation of the Psychometric Hepatic Encephalopathy Score (PHES) for identifying patients with minimal hepatic encephalopathy. Digestive Diseases and Sciences 2011 56 10 3014 3023 2-s2.0-79953226677 10.1007/s10620-011-1684-0
5. Gitlin N., Subclinical portal-systemic encephalopathy. American Journal of Gastroenterology 1988 83 1 8 11 2-s2.0-0023869627 (Pubitemid 18052898)
6. Montgomery J. Y., Bajaj J. S., Advances in the evaluation and management of minimal hepatic encephalopathy. Current Gastroenterology Reports 2011 13 1 26 33 2-s2.0-79551524286 10.1007/s11894-010-0150-z
7. Poordad F. F., Review article: the burden of hepatic encephalopathy. Alimentary Pharmacology and Therapeutics 2007 25 1 3 9 2-s2.0-33846446011 10.1111/j.1746-6342.2006.03215.x (Pubitemid 46148239)
8. Das A., Dhiman R. K., Saraswat V. A., Verma M., Naik S. R., Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. Journal of Gastroenterology and Hepatology 2001 16 5 531 535 2-s2.0-0035720629 10.1046/j.1440-1746.2001.02487.x (Pubitemid 34188860)
9. Quero J. C., Schalm S. W., Subclinical hepatic encephalopathy. Seminars in Liver Disease 1996 16 3 321 328 2-s2.0-0030451813 (Pubitemid 27029881)
10. Romero-Gómez M., Boza F., García-Valdecasas M. S., García E., Aguilar-Reina J., Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. American Journal of Gastroenterology 2001 96 9 2718 2723 2-s2.0-0034821089 10.1016/S0002-9270(01) 02692-2 (Pubitemid 32889211)
11. Habior A., Kraszewska E., Goś-Zaja̧c A., Gołȩbiowski M., Szutkowska-Hoser J., Niezielska K., Niewiadomska M., Pawluczyk-Dyjecińska M., Minimalna encefalopatia u chorych z marskościa̧ wa̧troby-ocena metod diagnostycznych i czȩstości wystȩpowania. Postȩpy NaukMedycznych 2008 11 769 778
12. Häussinger D., Hepatic encephalopathy. Acta Gastro-Enterologica Belgica 2010 73 4 457 464 2-s2.0-79952128853
13. Dhiman R. K., Saraswat V. A., Sharma B. K., Sarin S. K., Chawla Y. K., Butterworth R., Duseja A., Aggarwal R., Amarapurkar D., Sharma P., Madan K., Shah S., Seth A. K., Gupta R. K., Koshy A., Rai R. R., Dilawari J. B., Mishra S. P., Acharya S. K., Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. Journal of Gastroenterology and Hepatology 2010 25 6 1029 1041 2-s2.0-77952992962 10.1111/j.1440-1746.2010.06318.x
14. Amodio P., Montagnese S., Gatta A., Morgan M. Y., Characteristics of minimal hepatic encephalopathy. Metabolic Brain Disease 2004 19 3-4 253 267 2-s2.0-5444270552 10.1023/B:MEBR.0000043975.01841.de (Pubitemid 39361187)
15. Cauli O., Rodrigo R., Llansola M., Montoliu C., Monfort P., Piedrafita B., El Mlili N., Boix J., Agustí A., Felipo V., Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metabolic Brain Disease 2009 24 1 69 80 2-s2.0-60449084556 10.1007/s11011-008- 9115-4
16. Felipo V., Urios A., Montesinos E., Molina I., Garcia-Torres M. L., Civera M., Del Olmo J. A., Ortega J., Martinez-Valls J., Serra M. A., Cassinello N., Wassel A., Jordá E., Montoliu C., Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metabolic Brain Disease 2012 27 1 51 58 10.1007/s11011-011-9269-3
17. Felipo V., Butterworth R. F., Neurobiology of ammonia. Progress in Neurobiology 2002 67 4 259 279 2-s2.0-0036629585 10.1016/S0301-0082(02)00019-9 (Pubitemid 35229984)
18. Abbott N. J., Rönnbäck L., Hansson E., Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews Neuroscience 2006 7 1 41 53 2-s2.0-29244463365 10.1038/nrn1824 (Pubitemid 41828930)
19. Butterworth R. F., Giguère J. F., Michaud J., Lavoie J., Layrargues G. P., Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochemical Pathology 1987 6 1-2 1 12 2-s2.0-0023284378 10.1007/BF02833598
20. Butterworth R. F., Girard G., Giguere J. F., Regional differences in the capacity for ammonia removal by brain following portocaval anastomosis. Journal of Neurochemistry 1988 51 2 486 490 2-s2.0-0023684535
21. Haussinger D., Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogenesis in perfused rat liver. European Journal of Biochemistry 1983 133 2 269 275 2-s2.0-0020617293 (Pubitemid 13042901)
22. Norenberg M. D., Martinez-Hernandez A., Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Research 1979 161 2 303 310 2-s2.0-0018382256 10.1016/0006-8993(79)90071-4 (Pubitemid 9087410)
23. Blei A. T., Olafsson S., Therrien G., Butterworth R. F., Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 1994 19 6 1437 1444 2-s2.0-0028365123 10.1016/0270-9139(94)90240-2 (Pubitemid 24166466)
24. Brusilow S. W., Koehler R. C., Traystman R. J., Cooper A. J. L., Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 2010 7 4 452 470 2-s2.0-77957073688 10.1016/j.nurt.2010.05.015
25. Skowrońska M., Albrecht J., Alterations of blood brain barrier function in hyperammonemia: an overview. Neurotoxicity Research 2012 21 2 236 244 10.1007/s12640-011-9269-4
26. Srivastava A., Yadav S. K., Yachha S. K., Thomas M. A., Saraswat V. A., Gupta R. K., Pro-inflammatory cytokines are raised in extrahepatic portal venous obstruction, with minimal hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2011 26 6 979 986 2-s2.0-79955885167 10.1111/j.1440-1746.2011. 06706.x
27. Li T., Li X., Zhou W., Cui X., Ma L., Dynamic susceptibility contrast-enhanced first-pass perfusion MR imaging in patients with subclinical hepatic encephalopathy. Journal of Neuroradiology 2012 39 5 290 294 10.1016/j.neurad.2011.09.002
28. Abbott N. J., Romero I. A., Transporting therapeutics across the blood-brain barrier. Molecular Medicine Today 1996 2 3 106 113 2-s2.0-0030099527 10.1016/1357-4310(96)88720-X (Pubitemid 126407728)
29. Abbott N. J., Astrocyte-endothelial interactions and blood-brain barrier permeability. Journal of Anatomy 2002 200 6 629 638 2-s2.0-0036319335 10.1046/j.1469-7580.2002.00064.x (Pubitemid 34823054)
30. Abbott N. J., Patabendige A. A. K., Dolman D. E. M., Yusof S. R., Begley D. J., Structure and function of the blood-brain barrier. Neurobiology of Disease 2010 37 1 13 25 2-s2.0-70449529433 10.1016/j.nbd.2009.07.030
31. Wolburg H., Lippoldt A., Tight junctions of the blood-brain barrier: development, composition and regulation. Vascular Pharmacology 2002 38 6 323 337 2-s2.0-0036627211 10.1016/S1537-1891(02)00200-8 (Pubitemid 36398254)
32. Abbott N. J., Dynamics of CNS barriers: evolution, differentiation, and modulation. Cellular and Molecular Neurobiology 2005 25 1 5 23 2-s2.0-17644364388 10.1007/s10571-004-1374-y (Pubitemid 40558582)
33. Norenberg M. D., Bender A. S., Astrocyte swelling in liver failure: role of glutamine and benzodiazepines. Acta Neurochirurgica 1994 60 24 27 2-s2.0-0028321104
34. Clemmesen J. O., Larsen F. S., Kondrup J., Hansen B. A., Ott P., Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999 29 3 648 653 2-s2.0-0033055873 (Pubitemid 29109575)
35. Desjardins P., Du T., Jiang W., Peng L., Butterworth R. F., Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined. Neurochemistry International 2012 60 7 690 696 10.1016/j.neuint.2012.02.001
36. Wright G., Davies N. A., Shawcross D. L., Hodges S. J., Zwingmann C., Brooks H. F., Mani A. R., Harry D., Stadlbauer V., Zou Z., Williams R., Davies C., Moore K. P., Jalan R., Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology 2007 45 6 1517 1526 2-s2.0-34250327519 10.1002/hep.21599 (Pubitemid 46918336)
37. Wright G., Sharifi Y., Jalan R., Blood-brain barrier in liver failure: are cracks appearing in the wall? Liver International 2010 30 8 1087 1090 2-s2.0-79951657220 10.1111/j.1478-3231.2010.02282.x
38. Horowitz M. E., Schafer D. F., Molnar P., Increased blood-brain transfer in a rabbit model of acute liver failure. Gastroenterology 1983 84 5, part 1 1003 1011 2-s2.0-0020570402 (Pubitemid 13119914)
39. Nguyen J. H., Yamamoto S., Steers J., Sevlever D., Lin W., Shimojima N., Castanedes-Casey M., Genco P., Golde T., Richelson E., Dickson D., McKinney M., Eckman C. B., Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice. Journal of Hepatology 2006 44 6 1105 1114 2-s2.0-33746924079 10.1016/j.jhep.2005.09.019 (Pubitemid 44308227)
40. Chavarria L., Oria M., Romero-Gimenez J., Alonso J., Lope-Piedrafita S., Cordoba J., Diffusion tensor imaging supports the cytotoxic origin of brain edema in a rat model of acute liver failure. Gastroenterology 2010 138 4 1566 1573 2-s2.0-77949854341 10.1053/j.gastro.2009.10.003
41. Sawara K., Desjardins P., Chatauret N., Kato A., Suzuki K., Butterworth R. F., Alterations in expression of genes coding for proteins of the neurovascular unit in ischemic liver failure. Neurochemistry International 2009 55 1-3 119 123 2-s2.0-64949167332 10.1016/j.neuint.2009.01.023
42. Cauli O., Lpezlarrubia P., Rodrigo R., Agusti A., Boix J., Nietocharques L., Cerdn S., Felipo V., Brain region-selective mechanisms contribute to the progression of cerebral alterations in acute liver failure in rats. Gastroenterology 2011 140 2 638 645 2-s2.0-79251552307 10.1053/j.gastro.2010.10. 043
43. Lv S., Song H. L., Zhou Y., Li L. X., Cui W., Wang W., Liu P., Tumour necrosis factor- α affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure. Liver International 2010 30 8 1198 1210 2-s2.0-79951624699 10.1111/j.1478-3231.2010.02211.x
44. Tofteng F., Larsen F. S., Monitoring extracellular concentrations of lactate, glutamate, and glycerol by in vivo microdialysis in the brain during liver transplantation in acute liver failure. Liver Transplantation 2002 8 3 302 305 2-s2.0-0036200167 10.1053/jlts.2002.32283 (Pubitemid 34257214)
45. Kato M., Hughes R. D., Keays R. T., Williams R., Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 1992 15 6 1060 1066 2-s2.0-0026628303 10.1002/hep.1840150615
46. Kumar R., Shalimar, Sharma H., Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. Clinical Gastroenterology and Hepatology 2012 10 8 925 931
47. Albrecht J., Jones E. A., Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. Journal of the Neurological Sciences 1999 170 2 138 146 2-s2.0-0033619660
48. Mullen K. D., Szauter K. M., Kaminsky-Russ K., 'Endogenous' benzodiazepine activity in body fluids of patients with hepatic encephalopathy. The Lancet 1990 336 8707 81 83 2-s2.0-0025292201 10.1016/0140-6736(90)91594-Z (Pubitemid 20222808)
49. Goulenok C., Bernard B., Cadranel J. F., Thabut D., Di Martino V., Opolon P., Poynard T., Flumazenil versus placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis. Alimentary Pharmacology and Therapeutics 2002 16 3 361 372 2-s2.0-0036185729 10.1046/j.1365-2036.2002.01191.x (Pubitemid 34214514)
50. Norenberg M. D., Astroglial dysfunction in hepatic encephalopathy. Metabolic Brain Disease 1998 13 4 319 335 2-s2.0-0032427875 10.1023/A: 1020688925901 (Pubitemid 29063732)
51. Itzhak Y., Norenberg M. D., Ammonia-induced upregulation of peripheral-type benzodiazepine receptors in cultured astrocytes labeled with [3H]PK 11195. Neuroscience Letters 1994 177 1-2 35 38 2-s2.0-0028102418 10.1016/0304-3940(94)90038-8 (Pubitemid 24269423)
52. Itzhak Y., Roig-Cantisano A., Dombro R. S., Norenberg M. D., Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Research 1995 705 1-2 345 348 2-s2.0-0029562295 10.1016/0006-8993(95)01244-3 (Pubitemid 26038775)
53. Ahboucha S., Layrargues G. P., Mamer O., Butterworth R. F., Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy. Annals of Neurology 2005 58 1 169 170 2-s2.0-21844477555 10.1002/ana.20534 (Pubitemid 40962477)
54. Ahboucha S., Talani G., Fanutza T., Sanna E., Biggio G., Gamrani H., Butterworth R. F., Reduced brain levels of DHEAS in hepatic coma patients: significance for increased GABAergic tone in hepatic encephalopathy. Neurochemistry International 2012 61 1 48 53 10.1016/j.neuint.2012.03.020
55. Cauli O., Llansola M., Erceg S., Felipo V., Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra. Journal of Hepatology 2006 45 5 654 661 2-s2.0-33749044194 10.1016/j.jhep.2006.06.019 (Pubitemid 44466667)
56. Groeneweg M., Quero J. C., de Bruijn I., Hartmann I. J. C., Essink-Bot M. L., Hop W. C. J., Schalm S. W., Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998 28 1 45 49 2-s2.0-0031834155 10.1002/hep.510280108 (Pubitemid 28299984)
57. Sinke A. P., Jayakumar A. R., Panickar K. S., Moriyama M., Reddy P. V. B., Norenberg M. D., NF B in the mechanism of ammonia-induced astrocyte swelling in culture. Journal of Neurochemistry 2008 106 6 2302 2311 2-s2.0-50849122660 10.1111/j.1471-4159.2008.05549.x
58. Norenberg M. D., Jayakumar A. R., Rama Rao K. V., Panickar K. S., New concepts in the mechanism of ammonia-induced astrocyte swelling. Metabolic Brain Disease 2007 22 3-4 219 234 2-s2.0-35449004571 10.1007/s11011-007-9062-5 (Pubitemid 47624314)
59. Häussinger D., Schliess F., Kircheis G., Pathogenesis of hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2002 17 3 S256 S259 2-s2.0-0036454831 10.1046/j.1440-1746.17.s3.10.x (Pubitemid 35454294)
60. Mardini H., Smith F. E., Record C. O., Blamire A. M., Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia. Journal of Hepatology 2011 54 6 1154 1160 2-s2.0-79956074041 10.1016/j.jhep.2010.09.030
61. García-Martínez R., Córdoba J., Acute-on-chronic liver failure: the brain. Current Opinion in Critical Care 2011 17 2 177 183 2-s2.0-79953089427 10.1097/MCC.0b013e328344b37e
62. Shawcross D. L., Davies N. A., Williams R., Jalan R., Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. Journal of Hepatology 2004 40 2 247 254 2-s2.0-1642491776 10.1016/j.jhep.2003.10.016 (Pubitemid 38115829)
63. Shawcross D. L., Wright G., Olde Damink S. W. M., Jalan R., Role of ammonia and inflammation in minimal hepatic encephalopathy. Metabolic Brain Disease 2007 22 1 125 138 2-s2.0-33847613863 10.1007/s11011-006-9042-1 (Pubitemid 46354829)
64. Alvarez V. M., Rama Rao K. V., Brahmbhatt M., Norenberg M. D., Interaction between cytokines and ammonia in the mitochondrial permeability transition in cultured astrocytes. Journal of Neuroscience Research 2011 89 12 2028 2040 2-s2.0-79960048993 10.1002/jnr.22708
65. Rama Rao K. V., Norenberg M. D., Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy. Neurochemistry International 2012 60 7 697 706 10.1016/j.neuint.2011.09.007
66. Rama Rao K. V., Jayakumar A. R., Norenberg M. D., Ammonia neurotoxicity: role of the mitochondrial permeability transition. Metabolic Brain Disease 2003 18 2 113 127 2-s2.0-0038509984 10.1023/A:1023858902184 (Pubitemid 36718124)
67. Rao K. V., Norenberg M. D., Cerebral energy metabolism in Hepatic Encephalopathy and hyperammonemia. Metabolic Brain Disease 2001 16 1-2 67 78 2-s2.0-0035165599 10.1023/A:1011666612822 (Pubitemid 33064038)
68. Zwingmann C., Butterworth R., An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: further studies using NMR spectroscopy. Neurochemistry International 2005 47 1-2 19 30 2-s2.0-20544466584 10.1016/j.neuint.2005.04.003 (Pubitemid 40848689)
69. Chen Y., Swanson R. A., Astrocytes and brain injury. Journal of Cerebral Blood Flow and Metabolism 2003 23 2 137 149 2-s2.0-0037314008 (Pubitemid 36188452)
70. Norenberg M. D., The role of astrocytes in hepatic encephalopathy. Neurochemical Pathology 1987 6 1-2 13 33 2-s2.0-0023287036 10.1007/BF02833599
71. Butterworth R. F., Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy. Neurochemistry International 2010 57 4 383 388 2-s2.0-77956231926 10.1016/j.neuint.2010.03.012
72. Norenberg M. D., A light and electron microscopic study of experimental portal systemic (ammonia) encephalopathy. Progression and reversal of the disorder. Laboratory Investigation 1977 36 6 618 627 2-s2.0-0017735996 (Pubitemid 8138838)
73. Sokoloff L., Relation between physiological function and energy metabolism in the central nervous system. Journal of Neurochemistry 1977 29 1 13 26 2-s2.0-0017644156 (Pubitemid 8150483)
74. Lockwood A. H., Yap E. W. H., Wong W. H., Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. Journal of Cerebral Blood Flow and Metabolism 1991 11 2 337 341 2-s2.0-0025979046
75. Weissenborn K., Bokemeyer M., Ahl B., Fischer-Wasels D., Giewekemeyer K., Van Den Hoff J., Köstler H., Berding G., Functional imaging of the brain in patients with liver cirrhosis. Metabolic Brain Disease 2004 19 3-4 269 280 2-s2.0-5444229806 10.1023/B:MEBR.0000043976.17500.8e (Pubitemid 39361188)
76. Yazgan Y., Narin Y., Demirturk L., Saracoglu M., Ercan M., Akyatan N., Dalkanat N., Ozel A. M., Cetin M., Value of regional cerebral blood flow in the evaluation of chronic liver disease and subclinical hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2003 18 10 1162 1167 2-s2.0-0242656102 10.1046/j.1440-1746.2003.03141.x (Pubitemid 37410046)
77. Pomier-Layrargues G., Spahr L., Butterworth R. F., Increased manganese concentrations in pallidum of cirrhotic patients. The Lancet 1995 345 8951 735 2-s2.0-0028927312
78. Krieger D., Krieger S., Jansen O., Gass P., Theilmann L., Lichtnecker H., Manganese and chronic hepatic encephalopathy. The Lancet 1995 346 8970 270 274 2-s2.0-0029101204
79. Layrargues G. P., Shapcott D., Spahr L., Butterworth R. F., Accumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy? Metabolic Brain Disease 1995 10 4 353 356 2-s2.0-0029621974 10.1007/BF02109365 (Pubitemid 26042543)
80. Spahr L., Butterworth R. F., Fontaine S., Bui L., Therrien G., Milette P. C., Lebrun L. H., Zayed J., Leblanc A., Pomier-Layrargues G., Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996 24 5 1116 1120 2-s2.0-16044370086 10.1053/jhep.1996.v24.pm0008903385 (Pubitemid 26365913)
81. Tarter R. E., Sandford S. L., Hays A. L., Carra J. P., van Thiel D. H., Hepatic injury correlates with neuropsychologic impairment. International Journal of Neuroscience 1989 44 1-2 75 82 2-s2.0-0024317676
82. Tarter R. E., Hegedus A. M., van Thiel D. H., Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 1984 86 6 1421 1427 2-s2.0-0021361078 (Pubitemid 14147933)
83. Dhiman R. K., Chawla Y. K., Minimal hepatic encephalopathy. Indian Journal of Gastroenterology 2009 28 1 5 16 2-s2.0-67649600782 10.1007/s12664-009-0003-6
84. Kulisevsky J., Pujol J., Junque C., Deus J., Balanzó J., Capdevila A., MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration? Neurology 1993 43 12 2570 2573 2-s2.0-0027749450 (Pubitemid 24004547)
85. Powell E. E., Pender M. P., Chalk J. B., Parkin P. J., Strong R., Lynch S., Kerlin P., Cooksley W. G., Cheng W., Powell L. W., Improvement in chronic hepatocerebral degeneration following liver transplantation. Gastroenterology 1990 98 4 1079 1082 2-s2.0-0025254034 (Pubitemid 20095864)
86. Gupta A., Dhiman R. K., Kumari S., Rana S., Agarwal R., Duseja A., Chawla Y., Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. Journal of Hepatology 2010 53 5 849 855 2-s2.0-77957345947 10.1016/j.jhep.2010.05.017
87. Jun D. W., Kim K. T., Lee O. Y., Chae J. D., Son B. K., Kim S. H., Jo Y. J., Park Y. S., Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients. Digestive Diseases and Sciences 2010 55 5 1465 1471 2-s2.0-77953638458 10.1007/s10620-009-0870-9